Filing Details

Accession Number:
0000899243-17-018008
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-07-06 18:14:31
Reporting Period:
2017-07-05
Filing Date:
2017-07-06
Accepted Time:
2017-07-06 18:14:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1420565 Aileron Therapeutics Inc ALRN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1315797 A Muneer Satter C/O Aileron Therapeutics, Inc.
281 Albany Street
Cambridge MA 02139
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-07-05 144,773 $0.00 144,773 No 4 C Indirect See footnote
Common Stock Acquisiton 2017-07-05 33,333 $15.00 178,106 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See footnote
No 4 P Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series D Preferred Stock Disposition 2017-07-05 847,721 $0.00 85,309 $0.00
Common Stock Series E-2 Preferred Stock Disposition 2017-07-05 183,944 $0.00 18,511 $0.00
Common Stock Series E-3 Preferred Stock Disposition 2017-07-05 159,548 $0.00 16,055 $0.00
Common Stock Series F Preferred Stock Disposition 2017-07-05 247,398 $0.00 24,896 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
  2. These shares are held by the Muneer A. Satter Revocable Trust and various other trusts and entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive power over all such shares.